This study does provide estimates of TB outcome by degree of diabetic care as well as by type of anti-diabetic regimen used unlike Mahishale et al. Unadjusted RR derived from Magee et al revealed worse treatment outcomes among those on insulin. This evidence concerns the gene INS and tuberculosis.